INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,171,300 | -53.0% | 2,647,927 | -10.6% | 0.02% | -61.5% |
| Q4 2022 | $4,622,455 | +13.4% | 2,963,112 | +25.4% | 0.04% | -9.3% |
| Q3 2022 | $4,077,000 | +13.8% | 2,363,189 | +14.1% | 0.04% | +30.3% |
| Q2 2022 | $3,584,000 | -49.6% | 2,071,803 | +4.6% | 0.03% | -21.4% |
| Q1 2022 | $7,108,000 | +15.6% | 1,979,825 | +60.7% | 0.04% | +31.2% |
| Q4 2021 | $6,148,000 | +14.7% | 1,232,071 | +64.6% | 0.03% | -13.5% |
| Q3 2021 | $5,360,000 | -12.9% | 748,655 | +12.8% | 0.04% | -5.1% |
| Q2 2021 | $6,155,000 | -4.1% | 663,948 | -4.0% | 0.04% | -11.4% |
| Q1 2021 | $6,415,000 | +424.1% | 691,280 | +399.9% | 0.04% | +266.7% |
| Q4 2020 | $1,224,000 | -46.4% | 138,275 | -29.8% | 0.01% | -57.1% |
| Q3 2020 | $2,283,000 | +15.5% | 196,842 | +168.4% | 0.03% | 0.0% |
| Q2 2020 | $1,977,000 | +181.2% | 73,347 | -61.1% | 0.03% | +154.5% |
| Q1 2019 | $703,000 | – | 188,557 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |